Pantogastrix (Pantoprazole)

Pantoprazole, the active ingredient in Pantogastrix, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid production and is used to treat conditions such as gastro‑oesophageal reflux disease, erosive oesophagitis, peptic ulcer disease, and Zollinger‑Ellison syndrome in adult patients.

GNH USA supplies Pantogastrix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to European Union quality standards and provides reliable global distribution.

Pantogastrix (pantoprazole) is indicated for several acid‑related gastrointestinal disorders.

- Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and regurgitation by decreasing gastric acid exposure to the esophagus. - Erosive oesophagitis: promotes healing of acid‑induced esophageal lesions and prevents recurrence. - Peptic ulcer disease: supports ulcer healing and reduces risk of recurrence by maintaining a low‑acid environment. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors.

Pantogastrix may be associated with a range of adverse reactions, which are generally classified by frequency and severity.

Common Side Effects: - Headache: mild to moderate pain in the head region. - Diarrhea: loose, watery stools occurring intermittently. - Nausea: sensation of unease and urge to vomit. - Abdominal pain: cramping or discomfort in the stomach area. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Acute interstitial nephritis: inflammation of kidney interstitium requiring medical attention. - Severe allergic reaction (anaphylaxis): rapid onset of hives, swelling, and respiratory distress. - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Low magnesium levels (hypomagnesemia): muscle weakness, tremors, or cardiac arrhythmia. - Bone fracture: increased risk of fractures with long‑term use.

When prescribing Pantogastrix, clinicians should consider several precautionary measures to ensure safe use.

- Assess renal function: dose adjustment may be needed in patients with severe impairment. - Monitor for magnesium deficiency: prolonged therapy can lower serum magnesium. - Evaluate for Helicobacter pylori infection: consider eradication therapy before initiating treatment. - Use with caution in elderly patients: increased susceptibility to fractures and electrolyte disturbances. - Avoid concomitant use with drugs that require gastric acidity for absorption: may reduce their effectiveness. - Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Pantogastrix can affect the pharmacokinetics of other medicines; interactions are categorized by clinical significance.

Major Interactions (Avoid): - Ketoconazole and itraconazole: reduced antifungal absorption due to increased gastric pH. - Atazanavir: markedly decreased antiviral exposure, compromising efficacy. - Clopidogrel: diminished activation leading to reduced antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, requiring closer coagulation monitoring. - Digoxin: slight increase in serum levels, monitor for toxicity. - Methotrexate (high dose): potential for increased toxicity, assess renal function.